Inventor
LINDEN JOEL M
US31 patents
⚠️ This page may combine multiple inventors who share the name “LINDEN JOEL M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV VIRGINIA
20 patentsUS5877180AMar 2, 1999
Method for treating inflammatory diseases with A2a adenosine receptor agonists
UNIV VIRGINIA170 citations99
US6117878ASep 12, 2000
8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
UNIV VIRGINIA134 citations98
US6514949B1Feb 4, 2003
Method compositions for treating the inflammatory response
UNIV VIRGINIA92 citations97
US6670334B2Dec 30, 2003
Method and compositions for treating the inflammatory response
UNIV VIRGINIA62 citations96
US6545002B1Apr 8, 2003
Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
UNIV VIRGINIA73 citations96
US6303619B1Oct 16, 2001
Meta-substituted acidic 8-phenylxanthine antagonists of A3 human adenosine receptors
UNIV VIRGINIA62 citations96
US6232297B1May 15, 2001
Methods and compositions for treating inflammatory response
UNIV VIRGINIA112 citations96
US7214665B2May 8, 2007
2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
UNIV VIRGINIA45 citations94
US6322771B1Nov 27, 2001
Induction of pharmacological stress with adenosine receptor agonists
UNIV VIRGINIA131 citations94
US6448235B1Sep 10, 2002
Method for treating restenosis with A2A adenosine receptor agonists
UNIV VIRGINIA87 citations93
US7605143B2Oct 20, 2009
2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity
UNIV VIRGINIA25 citations92
US7576069B2Aug 18, 2009
2-polycyclic propynyl adenosine analogs having A2A agonist activity
UNIV VIRGINIA36 citations91
US7427606B2Sep 23, 2008
Method to reduce inflammatory response in transplanted tissue
UNIV VIRGINIA24 citations90
US7226913B2Jun 5, 2007
Pharmaceutical compositions having A2A adenosine receptor agonist activity
UNIV VIRGINIA23 citations90
US7378400B2May 27, 2008
Method to reduce an inflammatory response from arthritis
UNIV VIRGINIA32 citations89
US7875595B2Jan 25, 2011
2-polycyclic propynyl adenosine analogs having A2A agonist activity
UNIV VIRGINIA7 citations83
US7442687B2Oct 28, 2008
2-polycyclic propynyl adenosine analogs having A2A agonist activity
UNIV VIRGINIA13 citations83
US7737127B2Jun 15, 2010
2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
UNIV VIRGINIA12 citations82
US7396825B2Jul 8, 2008
Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
UNIV VIRGINIA13 citations79
US4376125AMar 8, 1983
Aminobenzlpropranolol and pharmaceutical preparation thereof
UNIV VIRGINIA7 citations72
Univ Virginia Patent Found
3 patentsUS6531457B2Mar 11, 2003
Methods and compositions for treating inflammatory response
Univ Virginia Patent Found63 citations94
US7989431B2Aug 2, 2011
2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity
Univ Virginia Patent Found6 citations73
US8012484B2Sep 6, 2011
Method of treating ischemia reperfusion injury by inhibiting NKT cell activity
Univ Virginia Patent Found3 citations56
LINDEN JOEL M
3 patentsUS7019027B2Mar 28, 2006
2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
LINDEN JOEL M38 citations90
US8158604B2Apr 17, 2012
2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
LINDEN JOEL M0 citations50
US8178509B2May 15, 2012
Method to treat sickle cell disease
LINDEN JOEL M0 citations34